Last reviewed · How we verify
Angina pectoris
Approved treatments
- Crodimyl
Crodimyl works by modulating the activity of a specific cellular pathway to improve blood flow to the heart. - Motazomin
Molsidomine works by releasing nitric oxide, which relaxes blood vessels and improves blood flow to the heart. - Vastarel
Trimetazidine works by optimizing the heart's energy production, reducing the amount of oxygen required by the heart muscle. - Ranexa · Menarini Intl
Ranexa works by blocking the sodium channels in heart muscle cells to reduce the amount of calcium that enters the cells during heart contractions. - Nitroglycerin · Fougera
Nitroglycerin forms nitric oxide, activating guanylate cyclase and increasing cyclic GMP, leading to smooth muscle relaxation and vasodilation. - Corlanor · Amgen
- Procardia · Pfizer
- Isoptin
- Lopressor · Generic (originally Ciba-Geigy/Novartis)
Cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, blood pressure, and myocardial oxygen demand. - Lipitor · Pfizer Inc.
Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. - Posicor
- Selecal
Selecal works by blocking beta-1 adrenergic receptors in the heart, reducing heart rate and blood pressure. - tenitramine
Tenitramine works by releasing nitric oxide, which relaxes blood vessels and improves blood flow to the heart. - Dinitrochlorhydrin
Clonitrate works by relaxing blood vessels to improve blood flow to the heart. - Selectol
- Cardizem · Generic (originally Tanabe Seiyaku)
- Inderal · Generic (originally ICI/AstraZeneca)
- Procardia · Pfizer
- Corgard · Uswm
- Monoket
- Lipitor · Pfizer
Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis. - Org 5730
- Cardene · Hikma Intl Pharms
Cardene works by blocking calcium channels in the heart and blood vessels, which helps to relax and widen blood vessels, reducing blood pressure and heart workload. - Tenoretic 100 · Twi Pharms
- Norvasc · Pfizer Inc.
Long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, reducing blood pressure and myocardial oxygen demand. - nitroglycerine · University Hospital, Ghent
- Ranexa · Midwest Cardiovascular Research Foundation
- Amlodipin · Boehringer Ingelheim
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Angina pectoris patent landscape — cliff calendar, originator estates, attackable patents
- Angina pectoris treatment landscape brief
- Angina pectoris treatment updates RSS
Frequently asked questions about Angina pectoris
What drugs treat Angina pectoris?
Tracked treatments include Crodimyl, Motazomin, Vastarel, Ranexa, Nitroglycerin, Corlanor, Procardia, Isoptin.
What is the treatment for Angina pectoris?
Standard treatment for Angina pectoris includes Crodimyl, Motazomin, Vastarel, Ranexa, Nitroglycerin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Angina pectoris patent cliff · Angina pectoris CI report
- Treatment: Crodimyl
- Treatment: Motazomin
- Treatment: Vastarel
- Treatment: Ranexa · Menarini Intl
- Treatment: Nitroglycerin · Fougera
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing